The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.
© Clarivate Analytics, Journal Citation Reports 2025
Journal Information
Full text access
Resultado del tratamiento con eritropoyetina humana recombinante en pacientes urémicos tratados con DPCA y hemodiálisis. Estudio comparativo
Visits
4073
T. García Falcón, M. Pérez Fontán, J. Moncalián, A. Rodríguez-Carmona, M. Cao, C. Fernández Rivera y F. Valdés
This item has received
Article information
Full text is only available in PDF




